Host Thomas Pfister, CFA interviews Robin Smith, M.D., CEO of NeoStem (Nasdaq: NBS)

Facebooktwitterlinkedinmail
Investing – Small-Cap Market Intelligence • 4m 41s

Host Thomas Pfister, CFA interviews Robin Smith, M.D., CEO of NeoStem (Nasdaq: NBS), a biopharmaceutical company pursuing the preservation and enhancement of human health globally through the development of cell based therapeutics that prevent, treat or cure disease by repairing and replacing damaged or aged tissue, cells and organs and restoring their normal function.

Facebooktwitterlinkedinmail